Simoctocog alfa for the treatment of hemophilia A
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2017.1391785
Abstract: ABSTRACT Introduction: Hemophilia A is the most frequent inherited bleeding disorder and most challenging coagulation disorder. To combat this, a number of new improved rFVIII/IX concentrates have recently been approved. Some of them are derived… read more here.
Keywords: simoctocog; alfa treatment; expert opinion; simoctocog alfa ... See more keywords
Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study
Sign Up to like & getrecommendations! Published in 2020 at "Haemophilia"
DOI: 10.1111/hae.14215
Abstract: European regulatory authorities request postmarketing safety and efficacy data for factor IX (FIX) products. read more here.
Keywords: alfa treatment; efficacy nonacog; safety efficacy; safety ... See more keywords